missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Tocris Bioscience™ RO 8191
Click to view available options
Menge:
10 mg
Packungsgröße:
10 Milligramm
Beschreibung
RO 8191 is an IFNα receptor 2 (IFNAR2) agonist (EC50 = 0.2 μM). RO 8191 induces phosphorylation and activation of STAT1 and STAT2. RO 8191 inhibits hepatitis C (HCV) cell culture-produced infectious particles and HCV subgenomic replicon (IC50 values 0.20 μM and 0.17 μM, respectively) and inhibits hepatitis B virus replication in cell cultures (IC50 = 0.1 μM). In an animal model RO 8191 inhibits prion invasion and prolongs survival; it also reverses the inhibitory effect of integrin β6 (ITGB6) on the JAK/STAT3 signaling and the epithelial-to-mesenchymal transition pathway and inhibits the proliferation, invasion, and migration of cervical cancer cells. Orally bioavailable.
Spezifikation
Spezifikation
| Chemischer Name oder Material | 8-(1,3,4-Oxadiazol-2-yl)-2,4-bis(trifluoromethyl)imidazo[1,2-a][1,8 ]naphthyridine |
| CAS | 691868-88-9 |
| Menge | 10 mg |
| Ziel | IFN-alpha/beta R2 |
| Summenformel | C14H5F6N5O |
| Reinheit | 0.98 |
Berichtigung von Produktinhalten
Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.
Name des Produkts
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu